XML 60 R46.htm IDEA: XBRL DOCUMENT v3.25.3
REVENUE AND SEGMENT INFORMATION - Significant expense categories (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
SEGMENT INFORMATION        
Total research and development $ 918 $ 1,826 $ 3,842 $ 5,592
Selling, general and administrative        
Total selling, general and administrative 8,610 8,260 26,209 26,097
Capital expenditures of the segment     100 200
Single reportable segment        
SEGMENT INFORMATION        
Clinical expenses 719 936 2,510 3,499
Other research and development expenses 199 890 1,332 2,093
Total research and development 918 1,826 3,842 5,592
Selling, general and administrative        
Royalty expense 285 354 826 1,594
Stock-based compensation 376 843 1,435 2,792
Legal, financial and consulting 1,061 824 3,063 2,325
Other general and administrative 6,888 6,239 20,885 19,386
Total selling, general and administrative $ 8,610 $ 8,260 $ 26,209 $ 26,097